Login

Login

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Tatva Chintan Pharma Chem Ltd.

NSE : TATVAEQ BSE : 543321 ISIN CODE : INE0GK401011Industry : Chemicals - Speciality

News

  • Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 28 Apr 2025 | 16:00 | Dion Global

    In continuation of our earlier announcement dated 25 April 2025 we would like to inform that the Earnings Call post announcement of financial results...more...

  • Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 25 Apr 2025 | 17:43 | Dion Global

    Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we would like to inform y...more...

  • Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Call Updates 25 Apr 2025 | 17:43 | Dion Global

    Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meetmore...

  • Tatva Chintan Pharm - Board Meeting Intimation 25 Apr 2025 | 17:30 | Dion Global

    TATVA CHINTAN PHARMA CHEM LIMITED has informed the Exchange about Board Meeting to be held on 02-May-2025 to consider and approve the Yearly...more...

  • Tatva Chintan Pharm - Board Meeting Intimation for Board Meeting Intimation For Intimation Of Board Meeting To Be Held On Fri 25 Apr 2025 | 17:28 | Dion Global

    Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 inter alia to cons...more...

  • Tatva Chintan Pharm - Updates 19 Apr 2025 | 15:39 | Dion Global

    Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Intimation of change in contact details of MUFG Intime India Private L...more...

  • Tatva Chintan Pharm - Intimation Of Change In Contact Details Of MUFG Intime India Private Limited, Registrar And Share Trans 19 Apr 2025 | 15:39 | Dion Global

    Intimation of change in contact details of MUFG Intime India Private Limited Registrar and share Transfer Agent (\RTA\) of the Company.more...

  • Tatva Chintan Pharm - Disclosure under SEBI Takeover Regulations 11 Apr 2025 | 18:40 | Dion Global

    Ajay Mansukhlal Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indi...more...

  • Tatva Chintan Pharm has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025 05 Apr 2025 | 18:30 | Dion Global

    As of March 2025 72.02% is owned by Indian Promoters and 27.98% by Public. Top five Promoters holding highest number of shares of Tatva Chintan Pharm...more...

  • Tatva Chintan Pharm - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 03 Apr 2025 | 16:43 | Dion Global

    Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018more...

  • Tatva Chintan Pharm - Certificate under SEBI (Depositories and Participants) Regulations, 2018 03 Apr 2025 | 16:38 | Dion Global

    Tatva Chintan Pharma Chem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • Tatva Chintan Pharm - Disclosure under SEBI Takeover Regulations 02 Apr 2025 | 18:35 | Dion Global

    Shekhar Rasiklal Somani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of In...more...

  • Tatva Chintan Pharm - Trading Window-XBRL 26 Mar 2025 | 10:03 | Dion Global

    Tatva Chintan Pharma Chem Limited has informed the Exchange about Closure of Trading Windowmore...

  • Tatva Chintan Pharm - Trading Window 26 Mar 2025 | 09:59 | Dion Global

    Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tr...more...

  • Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 24 Mar 2025 | 10:27 | Dion Global

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.more...

  • Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Call Updates 24 Mar 2025 | 10:26 | Dion Global

    Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meetmore...

  • Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Mar 2025 | 13:47 | Dion Global

    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.more...

  • Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Call Updates 18 Mar 2025 | 13:47 | Dion Global

    Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meetmore...

  • Tatva Chintan Pharm - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 31 Jan 2025 | 14:54 | Dion Global

    Transcript of the earnings call held on 28 January 2025 post announcement of financial results of the Company for the quarter and nine months ended 3...more...

  • Tatva Chintan Pharm - Analysts/Institutional Investor Meet/Con. Call Updates 31 Jan 2025 | 14:53 | Dion Global

    Tatva Chintan Pharma Chem Limited has informed the Exchange about Transcriptmore...

Enter Stock

DOW Jones40280.940.42%
Nasdaq17388.710.03%
S&P 5005536.520.20%
Nikkei 22535839.990.38%
Hang Seng22027.890.21%
Shanghai Composite3288.41-0.20%
Sensex80218.371.27%
NSE Index24328.51.20%
BSE 100LCTMC8972.671.24%
BSE Auto 500621.65%
BSE Bharat228402.691.60%
BSE CPSE 3692.441.98%

Commodity

Gold95244-0.50%
Silver974420.01%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 85.58(0.08 %)
GBP/INR 113.82(0.25 %)
EUR/INR 97.12(0.07 %)
JPY/INR 0.60(-0.48 %)
CAD/INR 61.57(-0.28 %)
HKD/INR 11.01(-0.09 %)